Arian Silver Produces First Silver-Lead Concentrate from Recently Constructed Processing Plant

Arian Silver Corporation ("Arian Silver" or the "Company"), a silver exploration, development and mining company focused on silver projects in the silver belt of Zacatecas, Mexico, is pleased to report that first concentrate production has been achieved at its wholly-owned San José project.

The Company has produced its first silver-lead concentrate from its recently constructed processing plant and has started the commissioning of the zinc flotation circuit. The Company anticipates first zinc concentrate production early in the second quarter of 2015.

It is anticipated that the throughput of the plant will be increased over the coming months until the maximum throughput of 1,500 tonnes per day is achieved.

Jim Williams, Chief Executive Officer of Arian Silver, commented:

"Our team has done a tremendous job in bringing this operation into production safely within a very short time period. I would like to take this opportunity to thank our staff in Mexico and London for their hard work and dedication in achieving this important milestone. I would also like to thank our shareholders for their continued support during this transitional period for the Company.

"We have successfully optimized the crushing circuit to produce a smaller than expected particle size which will be more beneficial during the milling stage. We have also commenced commissioning of the zinc circuit and expect to produce our first zinc concentrate early in the second quarter.

"Achieving first concentrate production is a major milestone for our Company and marks the transition to a new silver mining company."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.